Safety, anxiety and natalizumab continuation in JC virus-seropositive MS patients

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)108-111
JournalMultiple Sclerosis
Volume20
Issue number1
DOIs
Publication statusPublished - 2014

Cite this